Sophia Pantasis

Sophia Pantasis

Auto-generated profile, based on publicly available information

Sophia Pantasis

ETH Zurich

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2022 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
SPSophia Pantasis
Sophia Pantasis
JFJuliane Bauersfeld Friemel
Juliane Bauersfeld Friemel
SBSalome Mirjam Brütsch
Salome Mirjam Brütsch
ZHZehan Hu
Zehan Hu
SKSabrina Krautbauer
Sabrina Krautbauer
MBMattia Renato Bordoli
Mattia Renato Bordoli
Vertebrate lonesome kinase (VLK) is the only known extracellular tyrosine kinase, but its physiological functions are largely unknown. We show that VLK is highly expressed in hepatocytes of neonatal mice, but downregulated during adulthood. To determine the role of VLK in liver homeostasis and regeneration, we generated mice with a hepatocyte-specific knockout of the VLK gene (Pkdcc). Cultured progenitor cells established from primary hepatocytes of Pkdcc knockout mice produced a secretome, which promoted their own proliferation in 3D spheroids and proliferation of cultured fibroblasts. In vivo, Pkdcc knockout mice developed liver steatosis with signs of inflammation and perivascular fibrosis upon aging, combined with expansion of liver progenitor cells. In response to chronic CCl4-induced liver injury, the pattern of deposited collagen was significantly altered in these mice. The liver injury marker alpha-fetoprotein (AFP) was increased in the secretome of VLK-deficient cultured progenitor cells and in liver tissues of aged or CCl4-treated knockout mice. These results support a key role for VLK and extracellular protein phosphorylation in liver homeostasis and repair through paracrine control of liver cell function and regulation of appropriate collagen deposition. This article has an associated First Person interview with the first author of the paper.

23 September 2024 in Research Square
Verified
Preprint
Open access
PDF file
AGAmiq Gazdhar
Amiq Gazdhar
KFKleanthis Fytianos
Kleanthis Fytianos
BOBurak Ozan
Burak Ozan
EPEliane Pfister
Eliane Pfister
PKPetra Khan
Petra Khan
TGThomas Geiser
Thomas Geiser
Idiopathic pulmonary fibrosis (IPF) represents a terminal, age-related disease characterized by a complex pathophysiology. Recent studies have reported the presence of basal cells in IPF lungs, yet their specific role and impact on other cell types within the fibrotic lung remains unclear. Lung resident mesenchymal stem cells (MSCs) are a crucial resident stem cell population essential for maintaining lung homeostasis; MSCs exhaustion, a hallmark of aging, has been implicated in IPF through poorly understood mechanisms. In this study, we investigated the effects of hepatocyte growth factor (HGF), an anti-fibrotic factor, on MSCs quiescence using a bleomycin-induced lung injury model. RNA-sequencing analysis of basal cells isolated from IPF lungs identified upregulation of matrix metalloproteinase 24 (MMP24) in IPF (2.45±0.53) compared to non-IPF basal cells (1.12±0.2) (p˂0.05). Moreover, in vivo experiments indicated increased MMP24 levels in bleomycin injured lung homogenates compared to healthy lungs (6.89±0.78 vs 3.52±0.65 ng/mL) p<0.01, and decreased frequencies of activated lung MSCs in bleomycin-injured lungs compared to healthy lungs (21.8±6.2% vs 51.0±9.3%) p<0.01. Consistently, in vivo overexpression of MMP24 resulted in enhanced quiescence of lung MSCs and increased fibrosis. Conversely, in vivo HGF gene transfer increased frequencies of activated lung MSCs (27.5±3.2%, p<0.05) and reduced MMP24 levels in lung homogenates (4.39±0.38 ng/mL, p<0.001). Mechanistically, HGF reduced MMP24 expression through the YAP-1 pathway. Collectively, our findings uncover MMP24 as a pro-fibrotic mediator in IPF patients and in bleomycin injured lung and identify HGF-YAP1-MMP24 as a novel therapeutic axis in lung fibrosis.

13 November 2026 in Research Square
Verified
Preprint
Open access
PDF file
VSValerie Salazar
Valerie Salazar
SPSophia Pantasis
Sophia Pantasis
BJBenjamin Jourde
Benjamin Jourde
DEDoriane Eckert
Doriane Eckert
ACAmelie Sauty de Chalon
Amelie Sauty de Chalon
CPChristian Parker
Christian Parker
Despite decades of intense translational research on bone and cartilage, much remains unknown about enhancing tendon repair. To identify strategies for tendon regeneration, we immortalized multi-potent cells from embryonic limb buds of Scx-gfp mice. Clones with tenogenic potential were used to run genome-wide genetic screens to identify genes that regulate Scx-gfp. Pathway enrichment analysis uncovered a cluster of hits mapping to lysosomal nutrient sensing (LYNUS). Using Crispr-mediated gene ablation in 3 cell types from 3 species, we confirmed regulation of Scx-gfp by LYNUS pathway and a role for Ragulator and Rag GTPases in tenocyte differentiation and function. Molecular profiling of Lamtor1-deficient cells revealed profound shifts in autophagy and lipid metabolism that contribute to Scx induction and the chondrocyte/tenocyte cell fate decision through Gpnmb and cholesterol biosynthetic pathway. In vivo, Lamtor1+/- mice displayed improved repair of Achilles tendon injury as measured by tissue biomechanics and MRI. In rat rotator cuff, pharmacological inhibition of Lamtor1 modulated LYNUS pathway and tenocyte gene expression but surprisingly lacked therapeutic effects on clinically-relevant phenotypes. Our work reveals a novel role for LYNUS in tenocyte biology and murine Achilles tendon repair while underscoring challenges in translating in vitro tenocyte biology to clinically meaningful pharmacological effects in vivo.